Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Tamoxifen caused hair loss in a 52-year-old woman.

Long COVID patients have more health issues than non-infected people.

Finasteride does not prevent bladder cancer.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Researchers found two new genetic variants linked to Alzheimer's disease.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Women with irregular periods have a higher risk of heart disease.